Patents by Inventor Timothy-Yu

Timothy-Yu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12197598
    Abstract: Systems and methods for enabling cross-tenant access are provided. In particular, a computing device may receive an access request, from a user of a first tenant, requesting access to a resource of a plurality of resources on a shared collaborative channel of a second tenant. The computing device may further evaluate cross-tenant access policies of the first and second tenants to determine that access to the plurality of resources is authorized by the first and second tenants, validate that the user is a member of the shared collaborative channel, and generate a validation token indicating the user is validated to access the plurality of resources. Based on the validation token, the computing device may further validate that the user is in compliance with the cross-tenant access policies for accessing the resource and grant the user a set of permissions to access the resource.
    Type: Grant
    Filed: September 30, 2021
    Date of Patent: January 14, 2025
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Michael Thomas McLean, Ladislau Conceicao, Glenn David Block, Timothy Yu-Rui Chen, Dean Shiyu Chiang, Matthias Leibmann
  • Patent number: 11999953
    Abstract: The present invention features antisense oligonucleotides (AONs) for the treatment of diseases and disorders associated with the deleterious effects of transposable element insertion (e.g., long interspersed nuclear element-i (LINE-1), Arthrobacter luteus element (Alu), short interspersed nuclear element variable number tandem repeat Arthrobacter luteus element (SINE-VNTR-Alu) or (SVA), or endogenous retrovirus (ERV). In one aspect, the invention provides one or more antisense oligonucleotides complementary to a transposable element present in an intronic sequence within a gene. In another aspect, the invention provides a method for treating a subject having a genetic disorder associated with the insertion of a transposable element, the method involving administering to the subject one or more antisense oligonucleotides of any aspect delineated herein.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: June 4, 2024
    Assignee: The Children's Medical Center Corporation
    Inventors: Timothy Yu, Eunjung Alice Lee
  • Publication number: 20230111687
    Abstract: Systems and methods for enabling cross-tenant access are provided. In particular, a computing device may receive an access request, from a user of a first tenant, requesting access to a resource of a plurality of resources on a shared collaborative channel of a second tenant. The computing device may further evaluate cross-tenant access policies of the first and second tenants to determine that access to the plurality of resources is authorized by the first and second tenants, validate that the user is a member of the shared collaborative channel, and generate a validation token indicating the user is validated to access the plurality of resources. Based on the validation token, the computing device may further validate that the user is in compliance with the cross-tenant access policies for accessing the resource and grant the user a set of permissions to access the resource.
    Type: Application
    Filed: September 30, 2021
    Publication date: April 13, 2023
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Michael Thomas MCLEAN, Ladislau CONCEICAO, Glenn David BLOCK, Timothy Yu-Rui CHEN, Dean Shiyu CHIANG, Matthias LEIBMANN
  • Patent number: 11359199
    Abstract: Described herein are methods and compositions related to the modulation of progranulin expression or activity in the brain for the treatment of neurodegenerative diseases.
    Type: Grant
    Filed: August 25, 2021
    Date of Patent: June 14, 2022
    Assignees: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Peter Jungsoo Park, Jin Kuk Kim, Timothy Yu, Yu-Han Huang
  • Publication number: 20220154182
    Abstract: Described herein are methods and compositions related to the modulation of progranulin expression or activity in the brain for the treatment of neurodegenerative diseases.
    Type: Application
    Filed: March 19, 2020
    Publication date: May 19, 2022
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Peter Jungsoo PARK, Jin Kuk KIM, Timothy YU, Yu-Han HUANG
  • Publication number: 20210380982
    Abstract: Described herein are methods and compositions related to the modulation of progranulin expression or activity in the brain for the treatment of neurodegenerative diseases.
    Type: Application
    Filed: August 25, 2021
    Publication date: December 9, 2021
    Applicants: PRESIDENT AND FELLOWS OF HARVARD COLLEGE, THE CHILDREN'S MEDICAL CENTER CORPORATION
    Inventors: Peter Jungsoo PARK, Jin Kuk KIM, Timothy YU, Yu-Han HUANG
  • Publication number: 20030045138
    Abstract: A connector having a relatively high terminal density is provide for reducing the requirement of the electric currents in one signal terminal and increase the conducting efficiency. The connector includes plural first conducting components each having a first terminal and extended laterally, plural second conducting components each having at least two second terminals and extended laterally, and an insulating housing having plural slots for mounting the plural first conducting components and the plural second conducting components, wherein each first conducting component and each corresponding second conducting component are mounted in the respective slot, so as to contain a contact pad having plural pins.
    Type: Application
    Filed: August 20, 2002
    Publication date: March 6, 2003
    Applicant: Delta Electronics, Inc.
    Inventors: Bay Shao-Ru Su, Chen Yu Timothy Yu, Kun-Feng Chen, Szu-Lu Huang
  • Patent number: 6407920
    Abstract: A heat-dissipating assembly for removing a portion of heat from a heat-generating device includes a fan and a heat sink. The fan has holes. The heat sink has a base in contact with a surface of the heat-generating device, and first fins and second fins extending upwards from the base, wherein the second fins further have projecting plates corresponding to the holes and each of the projecting plates includes a pedestal and a fastening portion, the height of the pedestal being substantially the same as that of the fan, wherein the projecting plates are inserted into the corresponding holes and the fasting portions are bent so as to be in contact with the upper surface of the fan.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: June 18, 2002
    Assignee: Delta Electronics, Inc.
    Inventors: Hsu Jui-Yuan, Chen Yu Timothy Yu
  • Publication number: 20020048154
    Abstract: A fin-shaped heat dissipation apparatus for an electronic device. The fin-shaped heat dissipation apparatus has a thermal conductive plate and a fin-shaped heat sink. The fin-shaped heat sink is in a wave formed including alternative peaks and troughs. Either the troughs or the peaks are coupled to the thermal conductive plate, while the thermal conductive plate is coupled to the electronic device.
    Type: Application
    Filed: December 27, 2000
    Publication date: April 25, 2002
    Inventors: Timothy-Yu, Kelly-Shyu
  • Patent number: 6129598
    Abstract: The present invention discloses a power supply system with modularized and integrated cable interface configuration for providing power from an external power source to a plurality of subsystems in a personal computer. The power supply system includes a power cable for connecting the power supply system to the external power source. The power supply system further includes an output (O/P) cable having a first end and second end, the O/P cable including a plurality of cable groups wherein each of the cable groups including a subsystem plug module on the first end for connecting to a corresponding PC subsystems. The power supply system further includes an integrated PC receptive module for providing an interface with the O/P cable. The O/P cable further including an integrated O/P cable plug module on the second end for plugging the O/P cable into the integrated receptive module, wherein the integrated O/P plug module being in electric connection to each of the cable groups.
    Type: Grant
    Filed: June 23, 1997
    Date of Patent: October 10, 2000
    Assignee: Delta Electronic, Inc.
    Inventors: Chen Yu Timothy Yu, Jui-Yuan Hsu
  • Patent number: 4012528
    Abstract: .alpha.-Aminoalkyl-3-(1,2-dihydroxyethyl)-4-hydroxy-benzyl alcohols having .beta.-adrenergic stimulant activity, particularly as selective bronchodilators, are disclosed.
    Type: Grant
    Filed: June 13, 1975
    Date of Patent: March 15, 1977
    Assignee: SmithKline Corporation
    Inventors: Timothy Yu-Wen Jen, Carl Kaiser, Joe R. Wardell
  • Patent number: 3976641
    Abstract: Novel 7-oxocephalosporins and a process for preparing them are disclosed. These compounds are useful intermediates in the preparation of other cephalosporins which have antibacterial activity.
    Type: Grant
    Filed: November 14, 1974
    Date of Patent: August 24, 1976
    Assignee: SmithKline Corporation
    Inventors: John R. E. Hoover, Timothy Yu-Wen Jen
  • Patent number: 3957985
    Abstract: 7-Mandelamido-3-(1-oxidopyridylthiomethyl)-3-cephem-4-carboxylic acid and substituted derivatives which have antibacterial activity are disclosed.
    Type: Grant
    Filed: February 25, 1975
    Date of Patent: May 18, 1976
    Assignee: SmithKline Corporation
    Inventors: James S. Frazee, Timothy Yu-Wen Jen
  • Patent number: 3952101
    Abstract: .alpha.-Aminomethyl-5-hydroxy-2-pyridinemethanols having .beta.-adrenergic stimulant activity, particularly as selective bronchodilators, are prepared generally from a 2-pyridine-carboxaldehyde by reaction with an appropriate isocyanide, via an amide intermediate followed by reduction to an amine and finally catalytic hydrogenation to remove benzyl protective groups.
    Type: Grant
    Filed: April 14, 1975
    Date of Patent: April 20, 1976
    Assignee: SmithKline Corporation
    Inventors: Timothy Yu-Wen Jen, Carl Kaiser